Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Medtronic
AstraZeneca
Dow
McKesson

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088327

See Plans and Pricing

« Back to Dashboard

NDA 088327 describes LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER, which is a drug marketed by Fresenius Kabi Usa and Hospira and is included in seven NDAs. It is available from eleven suppliers. Additional details are available on the LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER profile page.

The generic ingredient in LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
Summary for 088327
Tradename:LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER
Applicant:Hospira
Ingredient:lidocaine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 088327
Physiological EffectLocal Anesthesia
Suppliers and Packaging for NDA: 088327
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER lidocaine hydrochloride INJECTABLE;INJECTION 088327 ANDA Hospira, Inc. 0409-4277 0409-4277-01 25 VIAL, MULTI-DOSE in 1 TRAY (0409-4277-01) > 20 mL in 1 VIAL, MULTI-DOSE (0409-4277-16)
LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER lidocaine hydrochloride INJECTABLE;INJECTION 088327 ANDA Hospira, Inc. 0409-4277 0409-4277-02 25 VIAL, MULTI-DOSE in 1 TRAY (0409-4277-02) > 50 mL in 1 VIAL, MULTI-DOSE (0409-4277-17)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2%
Approval Date:Jul 31, 1984TE:APRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Baxter
McKinsey
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.